Ask them all: Self-report universal prenatal substance use screening in the United States
Ask them all: Self-report universal prenatal substance use screening in the United States
复制标题
DOI：
10.1080/14659891.2019.1614233
复制
发表时间：
2019-09-03
影响因子：
0.8
通讯作者：
Schmitt, Catherine A.
中科院分区：
文献类型：
--
作者：
Elertson, Kathleen M.;Schmitt, Catherine A.
背景：美国阿片类药物使用率的增加已经造成了全国性的公共卫生危机。怀孕期间使用药物会增加不良出生结果的风险。国家咨询小组建议对所有妇女进行产前药物使用筛查。然而，有没有一个单一的方法或工具，建议普遍产前物质使用screen.Objective：本研究旨在评估的有效性，普遍筛查使用直接的方法自我报告的物质使用在pregnancy.Method：一个回顾性审查的去识别数据，以评估妇女的意愿，自我报告的物质使用，通过直接筛选。从24个月的产妇自我报告获得的数据进行了分析，以评估在产前period.Results的直接筛查方法的整体有效性：结果显示产妇物质使用披露率为9.7%，高于5.4%美国全国平均水平。结论：提高认识的产妇产前物质使用提供了机会，教育和支持怀孕早期。研究结果表明，直接的方法可以支持母亲自我报告的物质使用普遍产前筛查。需要对不同人群和临床环境进行额外的研究。
Background: Increasing rates of opioid use in the United States have created a national public health crisis. Substance use in pregnancy increases risk for poor birth outcomes. National advisory groups recommend screening all women for prenatal substance use. However, there is no single approach or tool recommended for universal prenatal substance use screening.Objective: This study seeks to evaluate the effectiveness of universal screening using a direct approach self-report of substance use in pregnancy.Method: A retrospective review of de-identified data to evaluate women's willingness to self-report substance use through direct screening. Data obtained from 24 months of maternal self-report were analyzed to assess the overall effectiveness of a direct screening method during the prenatal period.Results: Findings revealed maternal substance use disclosure rates of 9.7%, higher than the 5.4% United States national average.Conclusion: Increasing awareness of maternal prenatal substance use offers opportunity for education and support early in pregnancy. Findings suggest the direct method may support maternal self-report of substance use in universal prenatal screening. Additional study with diverse populations and clinical settings is needed.